Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP360845.RAzVm90W_O25Vhtp0Ilk4DgqvgZl4Bz1HhRQWhsw5_cdo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP360845.RAzVm90W_O25Vhtp0Ilk4DgqvgZl4Bz1HhRQWhsw5_cdo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP360845.RAzVm90W_O25Vhtp0Ilk4DgqvgZl4Bz1HhRQWhsw5_cdo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP360845.RAzVm90W_O25Vhtp0Ilk4DgqvgZl4Bz1HhRQWhsw5_cdo130_provenance.
- NP360845.RAzVm90W_O25Vhtp0Ilk4DgqvgZl4Bz1HhRQWhsw5_cdo130_assertion description "[The incidence of FLT3/ITD was 11.3% (9 out of 80 patients) in AML, with 25% (3 out of 12 patients) in acute promyelocytic leukemia (APL) and 8.8% (6 out of 68 patients) in non-M3 AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP360845.RAzVm90W_O25Vhtp0Ilk4DgqvgZl4Bz1HhRQWhsw5_cdo130_provenance.
- NP360845.RAzVm90W_O25Vhtp0Ilk4DgqvgZl4Bz1HhRQWhsw5_cdo130_assertion evidence source_evidence_literature NP360845.RAzVm90W_O25Vhtp0Ilk4DgqvgZl4Bz1HhRQWhsw5_cdo130_provenance.
- NP360845.RAzVm90W_O25Vhtp0Ilk4DgqvgZl4Bz1HhRQWhsw5_cdo130_assertion SIO_000772 12115363 NP360845.RAzVm90W_O25Vhtp0Ilk4DgqvgZl4Bz1HhRQWhsw5_cdo130_provenance.
- NP360845.RAzVm90W_O25Vhtp0Ilk4DgqvgZl4Bz1HhRQWhsw5_cdo130_assertion wasDerivedFrom befree-2016 NP360845.RAzVm90W_O25Vhtp0Ilk4DgqvgZl4Bz1HhRQWhsw5_cdo130_provenance.
- NP360845.RAzVm90W_O25Vhtp0Ilk4DgqvgZl4Bz1HhRQWhsw5_cdo130_assertion wasGeneratedBy ECO_0000203 NP360845.RAzVm90W_O25Vhtp0Ilk4DgqvgZl4Bz1HhRQWhsw5_cdo130_provenance.
- befree-2016 importedOn "2016-02-19" NP360845.RAzVm90W_O25Vhtp0Ilk4DgqvgZl4Bz1HhRQWhsw5_cdo130_provenance.